Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Adalimumab (Primary) ; Budesonide (Primary) ; Certolizumab pegol (Primary) ; Infliximab (Primary) ; Prednisone (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 05 Feb 2018 Planned End Date changed from 1 Aug 2017 to 1 Jun 2018.
- 05 Feb 2018 Planned primary completion date changed from 1 Aug 2016 to 1 Jun 2018.
- 05 Feb 2018 Status changed from recruiting to active, no longer recruiting.